首页> 外文会议>Photodynamic Therapy of Cancer II >Photodynamic therapy of human skin tumors using topical application of5-aminolevulinic acid, dimethylsulfoxide (DMSO), and edetic acid disodium salt(EDTA),
【24h】

Photodynamic therapy of human skin tumors using topical application of5-aminolevulinic acid, dimethylsulfoxide (DMSO), and edetic acid disodium salt(EDTA),

机译:使用5-氨基乙酰丙酸,二甲基亚砜(DMSO)和乙二胺四乙酸二钠盐(EDTA)局部应用光动力学疗法治疗人类皮肤肿瘤,

获取原文

摘要

Abstract: The results of photodynamic therapy (PDT) in 48 patients bearing basal cell carcinoma (BCC) and 7 patients with squamous cell carcinoma (SCC) of the skin are described. Five- aminolevulinic acid (5-ALA) was applied topically in two formulations. The first formulation contained 20% of 5-ALA in a base cream, and the second formulation (5-ALA composite cream), contained an additional 2% of dimethylsulfoxide (DMSO) and 2% of edetic acid disodium salt (EDTA). The creams were left on the skin for 2 - 5 hours. Production of protoporphyrin (PP) was measured in situ by a laser-induced fluorescence (LIF) method. The results of fluorescence measurement clearly indicate that PP accumulation in tumors induced by the 5-ALA composite cream was markedly higher than that induced by the 5-ALA cream. The tumors were light-irradiated (600 - 720 nm) after 4 - 5 hours of cream applications, using the light delivery system Versa-Light by a light dose of 100 J/cm$+2$/. The clinically superficial BCC tumors were highly responsive to PDT; the overall result in BCC patients was an 85.4% complete response. Histological examination showed an initial edematous reaction, followed by necrosis and complete disappearance of the tumor. The superficial SCC tumors showed a 100% complete response after PDT. The ulcerated nodular SCC showed partial responses. !15
机译:摘要:描述了48例患有基底细胞癌(BCC)的患者和7例皮肤鳞状细胞癌(SCC)患者的光动力疗法(PDT)的结果。五氨基乙酰丙酸(5-ALA)以两种配方局部使用。第一种配方在基础霜中含有20%的5-ALA,第二种配方(5-ALA复合霜)中还含有2%的二甲基亚砜(DMSO)和2%的乙二酸二钠盐(EDTA)。将乳霜留在皮肤上2-5小时。原卟啉(PP)的产生是通过激光诱导荧光(LIF)方法原位测量的。荧光测量结果清楚地表明,由5-ALA复合乳膏诱导的肿瘤中的PP积累显着高于由5-ALA乳膏诱导的肿瘤中的PP积累。乳膏施用4-5小时后,使用光递送系统Versa-Light以100J / cm 2 +2 2 /的光剂量对肿瘤进行光照射(600-720nm)。临床上浅表的BCC肿瘤对PDT有高度反应; BCC患者的总体结果是85.4%的完全缓解率。组织学检查显示最初的水肿反应,随后坏死和肿瘤完全消失。 PDT后浅表SCC肿瘤显示100%完全缓解。溃疡性结节性SCC表现出部分反应。 !15

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号